Octreotide treatment in a neonate with non-chylous pleural effusion
African Journal of Paediatric Surgery · 26.05.2026 · 10 (4) · 374-376
DOI: 10.67481/ajps.v10i4.618 ↗Kurz gefasst
Fachartikel in der Zeitschrift African Journal of Paediatric Surgery, online erschienen am 26.05.2026. Verfasst von Salih Kalay und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Fetal pleural effusion is a rare condition. While it may regress spontaneously, it may also continue up to the post-natal period. This condition may be treated by thoracentesis, thoracoabdominal shunt application and pleurodesis in the intrauterine period while thoracentesis or tube thoracostomy may be used in the post-natal period. In cases where the fluid is defined to represent chylothorax, octreotide, a somatostatin analogue, may be administered for treatment. In this case report, we discussed the outcomes of treatment with octreotide administered in a neonatal case under follow-up due to fetal pleural effusion and with non chylous ascites detected in the post-natal period.
Zitieren
APA
Kalay, S., Oztekin, O., Tezel, G., Demir, B. E., Akcakuş, M., & Oygur, N. (2026). Octreotide treatment in a neonate with non-chylous pleural effusion. African Journal of Paediatric Surgery, 10(4), 374-376. https://doi.org/10.67481/ajps.v10i4.618
Vancouver
Kalay S, Oztekin O, Tezel G, Demir BE, Akcakuş M, Oygur N. Octreotide treatment in a neonate with non-chylous pleural effusion. African Journal of Paediatric Surgery. 2026;10(4):374-376. doi:10.67481/ajps.v10i4.618
BibTeX
@article{Kalay2026,
author = {Kalay, Salih and Oztekin, Osman and Tezel, Gonul and Demir, Burak Emre and Akcakuş, Mustafa and Oygur, Nihal},
title = {Octreotide treatment in a neonate with non-chylous pleural effusion},
journal = {African Journal of Paediatric Surgery},
year = {2026},
volume = {10},
number = {4},
pages = {374--376},
doi = {10.67481/ajps.v10i4.618}
}
EUVIMED